Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

NCT01585428 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

NIH

Sponsor class

Conditions

Cervical Cancer
Oropharyngeal Cancer
Vaginal Cancer
Anal Cancer
Penile Cancer

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Young TIL
DRUG: Aldesleukin

Sponsor

National Cancer Institute (NCI)